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Abstract Growth and replication of the protozoan parasite Toxoplasma gondii within host 
cell entail the production of several effector proteins, which the parasite exploits for 
counteracting the host’s immune response. Despite considerable research to define the host 
signaling pathways manipulated by T. gondii and their effectors, there has been limited 
progress into understanding how individual members of the dense granule proteins (GRAs) 
modulate gene expression within host cells. The aim of this study was to evaluate whether T. 
gondii GRA15 protein plays any role in regulating host gene expression. Baby Hamster 
Kidney cells (BHK-21) were transfected with plasmids encoding GRA15 genes of either type 
I GT1 strain (GRA15I) or type II PRU strain (GRA15II). Gene expression patterns of 
transfected and nontransfected BHK-21 cells were investigated using RNA-sequencing 
analysis. GRA15I and GRA15II induced both known and novel transcriptional changes in the 
transfected BHK-21 cells compared with nontransfected cells. Pathway analysis revealed that 
GRA15II was mainly involved in the regulation of Tumor Necrosis Factor (TNF), NF-κB, 
HTLV-I infection and NOD-like receptor signaling pathways. GRA15I preferentially 
influenced the synthesis of unsaturated fatty acids in host cells. Our findings support the 
hypothesis that certain functions of GRA15 protein are strain-dependent; and that GRA15 
modulates the expression of signaling pathways and genes with important roles in T. gondii 
pathophysiology. A greater understanding of host signaling pathways influenced by T. gondii 
effectors, would allow the development of more efficient anti-T. gondii therapeutic schemes, 
capitalizing on disrupting parasite virulence factors to advance the treatment of toxoplasmosis. 
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Toxoplasma gondii is a zoonotic protozoan parasite capable of infecting almost any nucleated 
cell type in most species of warm-blooded mammals (Dubremetz 1998; Liu et al. 2015). 
Approximately 138 unique genotypes of T. gondii have been identified (Su et al. 2012). Of 
which genotypes I, II and III are the predominant lineages in North America and Europe 
(Howe et al. 1995). These genotypes have remarkable differences in their virulence in mice; a 
single parasite of the hypervirulent genotype I T. gondii strain can be 100% lethal to a mouse; 
however, genotype II (intermediate in virulence) and genotype III (avirulent) strains had LD50 
values of 103-104 and 104-105, respectively (Sibley et al. 1992; Howe et al. 1996; Saeij et al. 
2006). Parasites of genotype I have a greater ability to breach biological barriers than those of 
genotype II and genotype III (Boothroyd et al. 2002; Barragan et al. 2003). Differences in 
strain virulence are paralleled with strain-specific differences in the parasite-derived effector 
proteins originating from apical secretory organelles - such as microneme proteins (MICs), 
rhoptry proteins (ROPs) and dense granule proteins (GRAs) (Mercier et al. 2015; Hakimi et al. 
2017; Liu et al. 2017).  
T. gondii secretes a large array of polymorphic effector proteins, such as MICs, ROPs and 
GRAs, which are crucial for host cell invasion, intracellular growth and evasion of the host 
immune response (Fox et al. 2011; Bougdour et al. 2013; Braun et al. 2013; Ma et al. 2014). 
The GRAs, in particular, have been shown to contribute to T. gondii pathogenesis in multiple 
ways (Hakimi et al. 2017). GRA7/MyD88-dependent NF-κB activation has been linked to the 
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activation of TRAF6 and the generation of reactive oxygen species (ROS), leading to 
enhanced proinflammatory responses by macrophages (Yang et al. 2015). GRA16 regulates 
several genes associated with cell cycle progression and the p53 tumor suppressor pathway 
(Bougdour et al. 2013). GRA17 and GRA23 enable T. gondii to obtain more nutrients by 
altering parasitophorous vacuole membrane (PVM) permeability (Gold et al. 2015). The 
dense granule protein TgIS blocks the interferon (IFN) response by recruiting the Mi-2/NuRD 
repressor complex to STAT1 binding sites in the promoter regions of the responsive genes. 
GRA24 activates MAPK signaling and regulates expression of genes encoding growth factors 
and/or cytokines/chemokines that support the parasite replication (Braun et al. 2013). 
Of note is GRA15 in type II strains (GRA15II), a polymorphic protein, which has been 
shown to be essential in the activation of NF-κB pathway via induction of TRAF6 and IκB 
kinase (IKK), leading to phosphorylation and degradation of IκB, and IL-1β induction via 
activation of host caspase-1 (Rosowski et al. 2011; Gov et al. 2013). Interestingly, T. gondii 
type II-specific induction of the immunomodulatory microRNAs, miR-146a and miR-155, 
was found to be independent of GRA15, which is a known activator of these microRNAs 
(Cannella et al. 2014), suggesting that other effectors are likely to be involved in this process. 
Despite significant advances in our understanding of the basic biology of T. gondii GRAs and 
the identification of 30 different GRAs (Mercier et al. 2015), the full spectrum of host 
signaling mechanisms modulated by GRA15 remains to be elucidated and GRA15I-induced 
transcriptional responses has yet to be defined. 
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To further explore the biological function of T. gondii GRA15, we examined the 
transcriptomes of Baby Hamster Kidney cells (BHK-21) transfected with GRA15I or GRA15II. 
We hypothesized that transcriptomic analysis of host BHK-21 cells transfected with GRA15 
protein from different T. gondii genotypes may reveal new insights into the molecular 
mechanisms of genotype-specific virulence contributions of GRA15 effector to the 
pathogenesis of T. gondii. Results showed that GRA15I and GRA15II induced known and 
novel transcriptional changes in transfected BHK-21 cells. Notably, GRA15II was mainly 
involved in the regulation of TNF, NF-κB, HTLV-I infection and NOD-like receptor 
signaling pathways; whereas, GRA15I upregulated genes associated with the synthesis of 
unsaturated fatty acids, probably to meet the metabolic demands of the growing parasite 
within the host cells. 
 
Materials and methods 
 
Parasite and cell cultures 
 
Toxoplasma gondii tachyzoites, type I GT1 strain and type II PRU strain, were maintained by 
weekly passage in human foreskin fibroblast (HFF) cells at 37 °C with 5% CO2 in Dulbecco’s 
modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 10 
μg/ml gentamicin, as previously described (Wang et al. 2017). Baby Hamster Kidney cells 
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(BHK-21) used in the transfection experiments were purchased from the American Type 
Culture Collection (ATCC) and maintained in DMEM containing 5% FBS. 
 
Construction of the recombinant plasmids   
 
Total RNA from T. gondii GT1 strain was isolated using TRIzol reagent according to the 
manufacturer’s instructions (Invitrogen, USA) in order to generate a cDNA library. The 
fragment of GRA15 gene from GT1 strain encoding a 584-residue (from aa52 to aa635) 
peptide was amplified from cDNA using RT-PCR. The GRA15 PCR primers included 
GRA15-forward (5’-GGGGGATCCATAATTCGGTGGCTTGGGTATCTTAC-3’) and 
GRA15-reverse (5’-GGGGAATTCTCATGGAGTTACCGCTGATTGTGTG-3’). The PCR 
product was cloned into a pMD19-T vector (Takara, Dalian, China) and digested with the 
restriction enzymes BamHI and EcoRI. Digested fragments were purified and ligated into a 
pCMV-mCherry vector at the EcoRI and BamHI sites. The recombinant plasmid (designated 
pCMV-GRA15I) was transformed into E. coli DH5α strain (Transgen, Beijing, China) and 
verified by restriction digestion. The sequence of the GRA15 coding region was confirmed by 
sequencing (Sangon Biotech, Shanghai, China). The recombinant plasmid pCMV-GRA15II 
containing the fragment of the GRA15II gene encoding a 500-residue (from aa51 to aa550) 
peptide was similarly constructed, with the exception that total RNA was isolated from T. 




Expression analysis of recombinant plasmids in BHK-21 
 
BHK-21 cells (~80% confluent) were transfected with the recombinant plasmids 
(pCMV-GRA15I or pCMV-GRA15II) using Lipofectamine 2000 reagent (Life Technologies, 
USA), and harvested 48 hr post-transfection for Western blot analysis. Cells transfected with 
pCMV-GRA15I or pCMV-GRA15II were separately lysed using cell lysis buffer (Beyotime, 
China). After pelleting the cellular debris by centrifugation, cell proteins in the supernatant 
were collected and separated using 12% SDS-polyacrylamide gels, followed by transfer onto 
a polyvinylidene ﬂuoride (PVDF) membrane (Millipore, USA) at 15 mA for 30 min. The 
PVDF membrane was then incubated with anti-mCherry mouse monoclonal antibody for 2 hr, 
and HRP-labeled goat anti-mouse IgG antibody for 1 hr. Finally, DAB reagent (TIANGEN, 
China) was used to reveal peroxidase activity. The BHK-21 cells transfected with an empty 
pCMV-mCherry vector served as a control. 
 
Transcriptome sequencing and read alignment 
 
Here, the transcriptomic response of BHK-21 cells to T. gondii GRA15 protein was 
determined. We performed transcriptomic analysis of BHK-21 cells transfected with 
pCMV-GRA15I, pCMV-GRA15II or pCMV-mCherry. Three biological replicates were 
examined for each condition. RNA was extracted individually from each biological replicate 
using TRIzol reagent (Invitrogen, USA). The quality of RNA samples was assessed on RNA 
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6000 Nano LabChip using Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, 
USA). The concentration of RNA was determined using Nanodrop 2000 (Thermo Scientific, 
USA). Three micrograms of RNA sample from each biological replicate was used for the 
construction of transcriptome libraries with a NEBNext® Ultra™ RNA Library Prep Kit for 
Illumina® (NEB, USA), and the index codes were added. After ﬁltering low quality reads and 
removing adapters, high quality clean reads were aligned to the golden hamster genome using 
SOAPaligner/SOAP2. No more than 5 mismatches in the alignment were permitted. RNA 
isolation, library construction, RNA sequencing and reads alignment were performed at The 




Differential expression of RNAs was identified using the "DESeq" bioconductor package in R 
(Anders and Huber 2010). The Benjamini-Hochberg’s approach was used for adjusting false 
discovery rate (FDR). We defined genes as being differentially expressed between groups if 
they had an FDR adjusted P-value (q-value) of < 0.05. GO enrichment analysis was 
performed, and only GO terms with a corrected P-value < 0.05 were considered significantly 
enriched. KEGG database (http://www.genome.jp/kegg/) was used for pathway analysis, with 
a corrected P-value <0.05 was set as the threshold.  
 




Toxoplasma gondii expresses effectors during different stages of infection, suggesting that 
these effector molecules play critical roles in the parasite’s life cycle (Mercier et al. 2015; 
Hakimi et al. 2017; Liu et al. 2017). Indeed, growth and replication of T. gondii within the 
host cell require the production of multiple effector proteins that the parasite employs in order 
to establish a successful infection (Fox et al. 2011; Bougdour et al. 2013; Braun et al. 2013; 
Ma et al. 2014; Hakimi et al. 2017). Despite considerable research efforts, many questions 
remain about the level of impact that these effector proteins have on the host cell signaling 
pathways. To identify host factors that underpin T. gondii pathogenesis, we compared the 
transcriptomes of BHK-21 cells exposed to T. gondii GRA15 protein with untreated cells 
using a transcriptome sequencing (RNA-seq) approach. We focused on examining the effect 
of GRA15 protein in two T. gondii strains belonging to two different genotypes (type 1 GT1 
and type 2 PRU) on host cell transcriptomes. Global transcriptomic analysis revealed 
strain-specific gene expression patterns of GRA15-transfected BHK-21 cells; and identified 
candidate genes for future studies into the molecular mechanisms of host-T. gondii interaction. 
Our results add to the growing body of evidence that strain-specific polymorphism in T. 
gondii effectors released into host cells during infection can induce distinct differences in the 
modulation of host signaling pathways (Reese et al. 2011; Niedelman et al. 2012; Hakimi et al. 
2017). 
 




Fragments of GRA15I and GRA15II were successfully amplified from cDNA of T. gondii GT1 
strain and PRU strain, respectively (Fig. 1A); and recombinant pCMV-GRA15I and 
pCMV-GRA15II plasmids were successfully constructed. The resultant plasmids were 
confirmed by restriction enzyme digestion (Fig. 1B). To detect the expression of transduced 
genes, total protein was extracted from BHK-21 cells at 48 h post transfection. Western 
blotting analysis showed that BHK-21 cells transfected with pCMV-GRA15II or 
pCMV-GRA15I plasmids, expressed 82 kDa GRA15II-mCherry and 90 kDa 
GRA15I-mCherry fusion proteins, respectively (Fig. 2, lane 1 and lane 2). Cells transfected 
with the empty control pCMV-mCherry vector expressed a ~30 kDa protein (Fig. 2, lane 3). 
 
Analysis of differential gene expression  
 
The RNA integrity number values (RIN) of all 9 RNA extracts were >8.0, indicating the high 
quality of samples used as input to the RNA sequencing library preparation. RNA-seq raw 
data were submitted to the NCBI database under the accession number PRJNA394179. 
Comparing mRNA libraries from pCMV-GRA15I-transfected BHK-21 cells with BHK-21 
cells transfected with pCMV-mCherry, identified 128 differentially expressed genes (DEGs), 
of which 61 were up-regulated and 67 were down-regulated (Fig. 3A). Comparing mRNA 
libraries from BHK-21 cells transfected with pCMV-GRA15II to BHK-21 cells transfected 
with pCMV-mCherry identified 125 DEGs, including 96 up-regulated and 29 down-regulated 
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mRNAs (Fig. 3B). Clustering analysis of DEGs in the two treatment conditions compared 
with the control is shown in Fig. 3C. 
 
GO enrichment and KEGG analysis  
 
Using a corrected P-value <0.05 as a cut-off, no GO term was found significantly enriched. 
However, the top GO terms enriched in BHK-21 cells transfected with pCMV-GRA15I were 
involved in glucose metabolism, amino acid biosynthesis, entry into host cell, gene 
transcription and metabolic processes (Fig. 4A). The top enriched GO terms of DEGs in 
BHK-21 cells transfected with pCMV-GRA15II were involved in cell growth, immune 
response, inflammation and metal ion transport (Fig. 4B).  
KEGG enrichment analysis, based on a corrected P-value <0.05, indicated that DEGs in 
BHK-21 cells transfected with pCMV-GRA15I were significantly enriched in the synthesis of 
unsaturated fatty acids (Table 1). This indicated that the T. gondii GT1 strain might induce 
unsaturated FAs synthesis in host cells (compared to PRU strain) via GRA15I, possibly to 
meet the nutritional demands of the proliferating parasite. T. gondii contains three FAs 
synthesis pathways and can scavenge unsaturated FAs from host cells (Waller et al. 1998; 
Seeber et al. 2003; Ramakishnan et al. 2012). Lipids are key to the survival of T. gondii as an 
obligate intracellular parasite and unsaturated FAs are essential for sustaining the parasite 
growth and genesis of the membrane of the newly formed parasites (Gratraud et al. 2009; 
Alloatti et al. 2011; Ramakrishnan et al. 2013; Ramakrishnan et al. 2015).  
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In agreement with data from previous studies, GRA15II was found to activate the host 
NF-κB signaling pathway (Rosowski et al. 2011; Morgado et al. 2014). GRA15II was shown 
to activate the NF-κB pathway in HFFs independent of MyD88 and TRIF, but dependent on 
TRAF6 and the IKK complex (Rosowski et al. 2011). Our results showed that GRA15II 
activates NF-κB pathway downstream of TRAF2, TRAF3 and TRAF5, probably via the 
upregulation of the mitogen-activated protein kinase kinase kinase 14 (also known as 
NF-kappa-B-inducing kinase [NIK]), a key molecule involved in activating canonical and 
noncanonical NF-κB signaling pathway (Table 1, Fig. 5). Thus, it is possible that GRA15II 
contributes to the activation of NF-κB signaling pathway using a number of molecular 
mechanisms.  
Differential gene expression analysis showed that cells transfected with pCMV-GRA15II 
were significantly enriched in TNF, HTLV-I infection and NOD-like receptor signaling 
pathways (Table 1). Activation of these pathways can lead to the upregulation of several host 
molecules; such as NLR family pyrin domain containing 3 (Nlrp3), C-C motif chemokine 2, 
tumor necrosis factor and alpha-induced protein 3 (Tnfaip3), all play critical roles in immune 
and inflammatory responses (Ozaki et al. 2015; Hung et al. 2017). GRA15II alone, without 
involvement of the parasite, was found to induce CD40 expression in bone marrow-derived 
macrophages in a NF-κB-dependent manner, and to promote T. gondii immunity through the 
production of interleukin-12 (Morgado et al. 2014). The GRA15II-associated dysregulation of 
these immune pathways is possibly a strategy used by the parasite to evade or exploit NF-κB 
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immune signaling and other host defense pathways, to proliferate and persist within their 
hosts. 
The manipulation of NF-κB pathway by T. gondii remains undefined. Type 1 T. gondii 
strains can transiently block NF-κB nuclear translocation regardless of the host cell infected 
(Shapira et al. 2002). However, type 2 strains had the opposite effect through the activity of 
GRA15 (Rosowski et al. 2011). Another transcription factor, GRA7, was found to activate 
MAPK and NF-κB, and the proinflammatory cytokine expression in macrophages (Yang et al. 
2015). It is possible that other transcription factors with yet unknown molecular mechanisms 
are also involved in the regulation of the NF-κB pathway. We have recently shown that 
GRA15II interacts with mouse Luzp1, which is involved in regulating host non-coding RNA 
genes (Liu et al. 2017). It remains to be elucidated whether or not Luzp1 plays a role in the 
GRA15II-induced activation of the NF-κB signaling pathway.  
GRA15 appears to play additional roles in modulating the parasite’s interaction with host 
cells. Through activation of NF-κB pathway, GRA15II can induce polarization of 
macrophages to classically activated phenotype M1 (Jensen et al. 2011). M1 macrophages 
produce pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6 and IL-12, and high levels 
of ROS and nitric oxide (Gordon 2003), probably to limit the parasite growth, hence 
facilitating the establishment of chronic type II T. gondii infection. The proto-oncogene c-Myc 
is a key transcription factor, regulating the expression of many genes involved in critical host 
cellular processes; such as cell cycle progression, cell metabolism and apoptosis (Dang and 
Lewis 1997; Dang et al. 1999), and can be upregulated during T. gondii infection (Franco et al. 
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2014). Our data also showed that GRA15II induces upregulation of c-Myc in BHK-21 cells 
(additional file 3), suggesting that upregulation of c-Myc is a potential mechanism by which 
GRA15II inhibits apoptosis of infected host cells. 
In conclusion, we determined the host cell transcriptomic changes associated with 
exposure to T. gondii GRA15 protein. We analyzed RNA-seq data from BHK-21 cells 
expressing GRA15I protein of GT1 strain, or GRA15II protein of PRU strain and discovered 
altered signaling pathways in cells transfected with each protein compared to control cells. 
GRA15II was mainly involved in the regulation of TNF, NF-κB, HTLV-I and NOD-like 
receptor signaling pathways. GRA15I induced the synthesis of host unsaturated FAs. These 
results provide new insight into the role of GRA15II-NIK signaling in immune response 
against T. gondii, and confirmed the finding that GRA15II induces activation of host cell 
NF-κB signaling in a strain-specific, not a cell type-specific, manner. These previously 
unidentified features of the host transcriptomic response to T. gondii GRA15 extend our 
understanding of the cellular signaling pathways and effectors activated following T. gondii. 
Further investigations are required to better understand the interrelationship between 
synergistic effects of GRA15s on host cell regulatory networks.  
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Fig. 1 Generation of the recombinant plasmids. (A) Lane M: DNA marker. Lane 1 and lane 2 
represent gel electrophoresis of the GRA15I fragment and GRA15II fragment amplified from 
cDNA of T. gondii GT1 strain and T. gondii PRU strain, respectively. (B) Enzymatic 
digestion of the recombinant plasmids. Lane M: DNA marker. Lane 1 and lane 2 represent the 
recombinant plasmids pCMV-mCherry-GRA15I and pCMV-mCherry-GRA15II digested with 
EcoRI and BamHI, respectively. 
 
Fig. 2 Western immunoblotting analysis of the expressed protein products by positive 
plasmids. Lane 1: protein of the pCMV-mCherry-GRA15II-transfected BHK-21 cell lysate; 
lane 2: protein of the pCMV-mCherry-GRA15I-transfected BHK-21 cell lysate; and lane 3: 
protein of the empty pCMV-N-mCherry-transfected BHK-21 cell lysate. 
 
Fig. 3 Effects of Toxoplasma gondii GRA15 on host gene transcription. Volcano plots 
showing the differentially expressed genes (DEG) of BHK-21 cells transfected with (A) 
pCMV-mCherry-GRA15I or (B) pCMV-mCherry-GRA15II compared to control cells. Red: 
upregulated genes; green: downregulated genes; blue: non-differentially expressed genes. padj, 
adjusted P-value. (C) Heat map and hierarchical clustering showing expression values of all 
DEGs. Each column represents a different treatment condition and each row represents a 
gene.  
 
Fig. 4 Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) in 
the transfected BHK-21 cells. (A) Top GO terms in cells transfected with pCMV-GRA15I 
were involved in glucose metabolism, amino acid biosynthesis, metabolic processes, 
membrane remodeling, entry into host cell, and gene transcription. (B) GO terms of DEGs in 
cells transfected with pCMV-GRA15II were involved in cell growth, immune response, 
inflammation, and metal ion transport.  
 




















* All differentially expressed genes were upregulated. 
 
  
Signaling pathway Differentially expressed genes * 
Mediated by GRA15II 
  TNF  
 
C-X-C motif chemokine 2-like, Csf1, Mmp9, C-C motif 
chemokine 2, Tnfaip3, Csf2, Vcam1, C-X-C motif chemokine 
2-like, Icam1, NIK 
  NF-κB C-X-C motif chemokine 2-like, Plau, Bcl2l1, Tnfaip3, 
Vcam1, C-X-C motif chemokine 2-like, Icam1, NIK 
  HTLV-I infection Fosl1, Fzd4, Myc, Bcl2l1, Cdkn1a, Csf2, Vcam1, Zfp36 
Icam1, NIK 
  NOD-like receptor Nlrp3, C-X-C motif chemokine 2-like, C-X-C motif 
chemokine 2-like, Tnfaip3, C-C motif chemokine 2 
Mediated by GRA15I 
  Biosynthesis of  
  unsaturated fatty acids 
 
acyl-CoA desaturase, acyl-CoA desaturase 2-like, acyl-CoA 





Additional file 1: Gene expression profiling based on Fragments per Kilobase per Million 
mapped reads (FPKM) values. 
 
Additional file 2: Gene expression analysis of RNA-seq data, showing DEGs between 
BHK-21 cells transfected with pCMV-GRA15I and control BHK-21 cells transfected with 
pCMV-mCherry. 
 
Additional file 3: Gene expression analysis of RNA-seq data, showing DEGs between 
BHK-21 cells transfected with pCMV-GRA15II and control BHK-21 cells transfected with 
pCMV-mCherry. 
 
Additional file 4: Gene expression analysis of RNA-seq data, showing DEGs between  
BHK-21 cells transfected with pCMV-GRA15I and BHK-21 cells transfected with 
pCMV-GRA15II . 
 
 
 
